Cargando…
Retraction Note: Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479289/ https://www.ncbi.nlm.nih.gov/pubmed/36109709 http://dx.doi.org/10.1186/s12876-022-02495-4 |
| _version_ | 1784790755172155392 |
|---|---|
| author | Liu, Cheng Yang, Zongguo Wang, Lei Lu, Yunfei Tang, Bozong Miao, Hui Xu, Qingnian Chen, Xiaorong |
| author_facet | Liu, Cheng Yang, Zongguo Wang, Lei Lu, Yunfei Tang, Bozong Miao, Hui Xu, Qingnian Chen, Xiaorong |
| author_sort | Liu, Cheng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9479289 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94792892022-09-17 Retraction Note: Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats Liu, Cheng Yang, Zongguo Wang, Lei Lu, Yunfei Tang, Bozong Miao, Hui Xu, Qingnian Chen, Xiaorong BMC Gastroenterol Retraction Note BioMed Central 2022-09-15 /pmc/articles/PMC9479289/ /pubmed/36109709 http://dx.doi.org/10.1186/s12876-022-02495-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Retraction Note Liu, Cheng Yang, Zongguo Wang, Lei Lu, Yunfei Tang, Bozong Miao, Hui Xu, Qingnian Chen, Xiaorong Retraction Note: Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats |
| title | Retraction Note: Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats |
| title_full | Retraction Note: Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats |
| title_fullStr | Retraction Note: Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats |
| title_full_unstemmed | Retraction Note: Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats |
| title_short | Retraction Note: Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats |
| title_sort | retraction note: combination of sorafenib and gadolinium chloride (gdcl3) attenuates dimethylnitrosamine(dmn)-induced liver fibrosis in rats |
| topic | Retraction Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479289/ https://www.ncbi.nlm.nih.gov/pubmed/36109709 http://dx.doi.org/10.1186/s12876-022-02495-4 |
| work_keys_str_mv | AT liucheng retractionnotecombinationofsorafenibandgadoliniumchloridegdcl3attenuatesdimethylnitrosaminedmninducedliverfibrosisinrats AT yangzongguo retractionnotecombinationofsorafenibandgadoliniumchloridegdcl3attenuatesdimethylnitrosaminedmninducedliverfibrosisinrats AT wanglei retractionnotecombinationofsorafenibandgadoliniumchloridegdcl3attenuatesdimethylnitrosaminedmninducedliverfibrosisinrats AT luyunfei retractionnotecombinationofsorafenibandgadoliniumchloridegdcl3attenuatesdimethylnitrosaminedmninducedliverfibrosisinrats AT tangbozong retractionnotecombinationofsorafenibandgadoliniumchloridegdcl3attenuatesdimethylnitrosaminedmninducedliverfibrosisinrats AT miaohui retractionnotecombinationofsorafenibandgadoliniumchloridegdcl3attenuatesdimethylnitrosaminedmninducedliverfibrosisinrats AT xuqingnian retractionnotecombinationofsorafenibandgadoliniumchloridegdcl3attenuatesdimethylnitrosaminedmninducedliverfibrosisinrats AT chenxiaorong retractionnotecombinationofsorafenibandgadoliniumchloridegdcl3attenuatesdimethylnitrosaminedmninducedliverfibrosisinrats |